Localised plasma-cell type castleman's disease and AA-amyloidosis cured by resection. A case report and review of the literature

Acta Clinica Belgica

Volumn 60, Issue 1, 2005, Pages 22-27

  Verbrugghe, W ^a   Maes, B D ^a   Knockaert, D C ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYLOIDOSIS; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CASE REPORT; EXPERIENCE; FEMALE; HISTOPATHOLOGY; HUMAN; KIDNEY FUNCTION; LYMPH NODE BIOPSY; LYMPHOPROLIFERATIVE DISEASE; NEPHROTIC SYNDROME; PATHOGENESIS; PLASMA CELL; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; TUMOR LOCALIZATION;

EID: 20444371551     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2005.006     Document Type: Review

References (52)

1. Atypical lymphoproliferative diseases. In: The American Society of Hematology Education Program Book 2000. San Francisco: American Society of Hematology. 2000: 133-146
2. Castleman B, Iverson L, Menendex V. Localised mediastinal lymph-node hyperplasia resembling thymoma. Cancer 1956, 9, 822-30.
3. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell type of giant lymph node hyperplasia of the mediastinum and other locations. Cancer, 1972, 29, 670-683
4. Weisenburger DD, Nathwani BN, Winberg CD et al. Multicentric angiofollicular lymph node hyperplasia: a clinicopathological study of 16 cases. Hum Pathol 1985, 16, 162-172
5. Frizzera G, Masarelli G, Banks PM et al. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients. Am J Surg Pathol, 1983, 7, 211-31
6. Altiparmak M., Pamuk G, Pamuk Ö. Secondary amyloidosis in Castleman's disease: review of the literature and report of a case. Ann Hematol, 2002, 81, 336-9
7. Aranda FI, Lopez JI, Prat J. Angiofollicular lymph node hyperplasia associated with amyloidosis. Surg Pathol, 1989, 2, 241-7
8. Armsoy T, Yilmaz M, Ataoglu O et al: Castleman's disease with renal amyloidosis and nephritic syndrome. Nephrol Dial Transplant, 1997, 12, 2713-6
9. Bonneau R, Paquin F, Giroux L. Angiofollicular lymph node hyperplasia of the plasma cell type with nephrotic syndrome and systemic amyloidosis: an unusual association. Lab Invest, 1982, 46, 10-11A
10. Chan WC, Hargreaves H, Keller J. Giant lymph node hyperplasia with unusual clinicopalhologic features. Cancer, 1984, 53, 2135-9
11. Curioni S., D'Amico M., Quartagno R, et al. Castleman's disease with nephrotic syndrome, amyloidosis and autoimmune manifestations. Nephrol Dial Transplant, 2001, 16, 1475-8
12. Funabiki K, Kaneko S, Terajima M et al. A case of multicentric Castleman's disease associated with renal amyloidosis and pure red cell aplasia. Am J Nephrol, 1998, 18, 247-50
13. Ikeda S, Chisuwa H, Kawasaki S et al. Systemic renal amyloidosis associated with Castleman's disease: serial changes of the concentration of acute phase serum amyloid A and interleukine 6 in serum. J Clin Pathol, 1997, 50, 965-7
14. Kanoh T, Shimada H, Uchino H et al. Amyloid goiter with hypothyroidism. Arch Pathol Lab Med, 1989, 113, 542-44
15. Kazes I, Deray G, Jacobs C. Castleman disease and renal amyloidosis. Ann Intern Med, 1995, 122, 395-6
16. Keven K., Nergizoglu G., Ates K et al. Remission of nephrotic syndrome after removal of localised Castleman's disease. Am J Kidney Disease, 2000, 35(6), 1207-1211
17. Lachmann HJ, Gilbertson JA, Gillmore JD. Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease. Q J Med, 2002, 95, 211-8
18. Montoli A., Minola E., Stabile F. et al. End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman's disease). Am J Nephrol, 1995, 15, 142-6
19. Moon WK, Kim SH, Im JG et al. Castleman disease with renal amyloidosis: imaging findings and clinical significance. Abdom Imaging, 1995, 20, 376-8
20. Nishimoto N, Sasai M, Shima Y, Nakagawa M et al. Improvement in Castleman's disease by humanised anti-interleukin-6 receptor antibody therapy. Blood, 2000, 95, 56-61
21. Paydas S, Gonlusen G, Sagliker Y. Regression of nephrotic syndrome with colchicines therapy secondary to amyloidosis with associated Castleman's disease. Nephron 1995, 71, 403-4
22. Perfetti V, Belloti V, Maggi A et al. Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localised Castleman's disease. Am J Hematology, 1994, 46, 189-93
23. Pilon VA, Gomez LG, Butler JJ. Systemic amyloidosis associated with a benign mesenteric lymphoid mass. Am J Clin Pathol, 1982, 78, 112-6
24. Tanaka K, Horita M, Shibayama H et al. Secondary amyloidosis associated with Castleman's disease. Intern Med, 1995, 34, 122-6
25. West KP, Morgan DR, Lauder I. Angiofollicular lymph node hyperplasia with amyloidosis. Postgrad Med J, 1989, 65, 108-11
26. Chan TM:, Cheng IKP, Wong K et al. Resolution of membranoproliferative glomemlonephritis complicating angiofollicular lymph node hyperplasia (Castleman's disease). Nephron, 1993, 65, 628-32
27. Chan KW, Chan MK, Choy DTK. Nephrotic syndrome associated with angiofollicular lymph node hyperplasia. Pathology, 1987, 19, 429-32
28. Combe C, Bouchet JL, Potaux L et al. Maladie de Castleman et néphropathie glomerulaire (a propos d'un cas). Néphrologie, 1989, 10, 163-6
29. Diebold J, Tulliez M, Bernadou A et al. Angiofollicular and plasmacytic polyadenopathy: a pseudotumourous syndrome with dysimmunity. J Clin Pathol, 1980, 33, 1068-76
30. Genin R, Justrabo E, Devillebichot C et al. Gloméruloné phrite membrano-proliférative et pseudo-tumeur de Castleman. J Urol Néphrol, 1978, 84, 667-72
31. Humpherys SR, Holley KE, Smith LH et al. Mesenteric angiofollicular lymph node hyperplasia (lymphoid hamartoma) with nephritic syndrome. Mayo Clin Proc 1975, 50, 317-21
32. Lajoie G, Kumar S, Min KW et al. Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases. Am J Surg Pathol, 1995, 19, 1021-8
33. Lui SL, Chan KW, Li FK et al. Castleman's disease and mesangial proliferative glomerulonephritis: the role of interleukine 6. Nephron, 1998, 78, 323-7
34. Miadonna A, Salmaso C, Palazzi P et al. Fibrillary glomerulonephritis in Castleman's disease. Leukemia and lymphoma, 1997, 28, 429-35
35. Riyad S, Mesleh T. Membranoproliferative glomerulonephritis associated with multicentric angiofollicular lymph node hyperplasia. Am J Nephrol, 1992, 12, 466-70
36. Ruggieri G, Barsotti P, Coppola G et al. Membranous nephropahthy associated with giant lymph node hyperplasia. Am J Nephrol, 1990, 10, 323-8
37. Tsukamoto Y, Kanada N, Nomura Y et al. Rapidly progressive renal failure associated with angiofollicular lymph node hyperplasia. Am, J Nephrol, 1991, 11, 430-6
38. Weisenburger DD. Membraneous nephropathy, its association with multicentric angiofollicular lymph node hyperplasia. Arch Pathol Lab Med, 1979, 103, 591-4
39. Herrada J, Cabanillas F, Rice L et al. The clinical behavior of localised and multicentric Castleman's disease. Ann Intern Med, 1998, 128, 657-62
40. Hengge UR, Ruzicka T, Tyring SK. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis, 2002, 2, 344-52
41. Soullier J, Grolet L, Oksenhendler E et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood, 1995, 86, 1276-80
42. Çagirgan S, Cirit M, Ok E et al. Castleman's disease in a renal allograft recipient. Nephron, 1997, 76, 352-3
43. Mandel C, Silbertstein M, Hennessy O. Case report: Fatal pulmonary Kaposi's sarcoma and Castleman's disease in a transplant recipient. Br J Radiol, 1993, 66, 264-5
44. Su-ming HSU, Waldron JA, Xie SS et al. Expression of interleukin-6 in Castleman's disease. Hum Pathol, 1993, 24, 833-9
45. Kinney MC, Hummel DS, Villiger PM et al. Increased interleukin-6 production in a young child with clinical and pathologic features of multicentric Castleman's disease. J Clin Immimol, 1994, 14, 382-90
46. Kunishima S, Taniguchi H, Koh T et al. F-18 Fluorodeoxyglucose positron emission tomography in mesenterial Castleman's lymphoma. Clin Nucl Med, 2001, 26, 789-90
47. Beck JT, Hsu SM, Wijdenes J et al. Brief Report: alleviation of systemic manifestation of Casteleman's disease by monoclonal anti-interleukine 6 antibody. NEJM, 1994, 330, 602-5
48. Stokes SH, Griffith RC, Thomas PRM. Angiofollicular lymph node hyperplasia (Castleman's disease) associated with vertebral destruction. Cancer, 1985, 56, 876-9
49. Summerfield GP, Taylor W, Bellingham AJ et al. Hyaline-vascular variant of angiofollicular lymph node hyperplasia with systemic manifestations and response to corticosteroids. J Clin Pathol, 1983, 36, 1005-11
50. Shahidi H, Myers JL, Kvale PA. Castleman's disease. Mayo Clin Proc, 1995, 70, 969-77
51. Bowne WB, Lewis JJ, Filipa DA et al. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer, 1999, 85, 706-17
52. Leger-Ravet MB, Peuchmaur O, Devergne O et al. Interleukin-6 gene expression in Castleman's disease. Blood, 1991, 11, 2923-30